Online registrations will be opening soon
Biologist
Chemist
Medical Surgeon
Pharmacist
Physicist
Veterinary
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia, Italy
English
Simultaneous translation
will not be provided
The SIC Annual Meeting is the focal point of the Italian cancer research community, where preclinical and clinical scientists gather together to share the latest advances in cancer research and cure. In the last few years, we have witnessed, as never before, the rapid translation of preclinical research into clinical application.
The program of the 62nd SIC Annual Meeting, entitled “The exciting path from preclinical research to clinical application” will focus on the challenges posed by the rapid development of the precision medicine approaches, including the need for a better understanding of tumor heterogeneity and drug resistance mechanisms, and the ongoing efforts necessary for a better patients stratification for radio-, chemo-, targeted- and immune- therapies, to increase the number of patients with durable clinical responses.
The meeting will be of interest for both preclinical and clinical researchers, working in different areas of cancer research.
In light of this broad attendance, we have designed scientific sessions in which most compelling topics will be discussed from different perspectives.
Participants to this CME event will thus have the opportunity to gain new knowledge and discuss several aspects of cancer research, including:
How particular targeted agents, radiotherapy and immunotherapies have been selected for their use, in patients with advanced cancer.
How to integrate the use of molecular profiling to select the most appropriate treatment for each patient.
How to evaluate the role of new emerging drugs and which is the biology underlying their efficacy.
Which are the main mechanisms of drug resistance and how combination therapies may increase treatment response or durability.
For the first time in Venice, SIC this year will also hold an open session dedicated to survivors, patients, care givers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients’ quality of life.
The abstract book is now available for download.
RESIDENTIAL Not available | RESIDENTIAL Not available | VIRTUAL Not available | VIRTUAL Not available | LAST MINUTE | |
---|---|---|---|---|---|
EACR - SIC member | 420,00 € | 500,00 € | 150,00 € | 200,00 € | 90,00 € |
SIC member under 35 | 280,00 € | 330,00 € | 120,00 € | 150,00 € | - |
NON member | 500,00 € | 600,00 € | 200,00 € | 250,00 € | 150,00 € |
NON member under 35 | 380,00 € | 400,00 € | 150,00 € | 200,00 € | - |
VAT included. The VAT rate will be applied depending on the Italian fiscal law at the time of payment.
Last minute fees are now available.
Virtual registrations will be possible until Monday, November 21st.
Maximum number of participants has been reached (350).
To access the waiting list, please send an email to SIC2022@meetingsrl.eu
Please specify “waiting list_name and surname_SIC2022” as the object of your email.
We also inform you that on-site registration is not allowed.
Residential registration fees include:
RESIDENTIAL Not available | RESIDENTIAL Not available |
|
---|---|---|
EACR - SIC member | 420,00 € | 500,00 € |
SIC member under 35 | 280,00 € | 330,00 € |
Non member | 500,00 € | 600,00 € |
Non member under 35 | 380,00 € | 400,00 € |
VIRTUAL Not available | VIRTUAL Not available |
|
---|---|---|
EACR - SIC member | 150,00 € | 200,00 € |
SIC member under 35 | 120,00 € | 150,00 € |
Non member | 200,00 € | 250,00 € |
Non member under 35 | 150,00 € | 200,00 € |
LAST MINUTE | |
---|---|
EACR - SIC member | 90,00 € |
SIC member under 35 | - |
Non member | 150,00 € |
Non member under 35 | - |
VAT included. The VAT rate will be applied depending on the Italian fiscal law at the time of payment.
Registration fees include:
Gustavo Baldassarre
Head of the Molecular Oncology Unit,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Fabio Puglisi
Head of the Department of Medical Oncology,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Professor of Medical Oncology,
Head of the School of Medical Oncology,
Department of Medicine, University of Udine, Italy.
Barbara Belletti
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Vincenzo Canzonieri
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN) – University of Trieste
Saverio Cinieri
“Sen. Antonio Perrino Hospital”, Brindisi – AIOM President
Pierfranco Conte
Istituto Oncologico Veneto IOV-IRCCS, University of Padova
Giannino Del Sal
Department of Life Sciences, University di Trieste – ICGEB-InternationaI Centre for Genetic Engineering and Biotechnology, Trieste – IFOM ETS, The AIRC Institute of Molecular Oncology, Milan
Silvia Franceschi
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Valter Gattei
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Valentina Guarneri
Istituto Oncologico Veneto IOV-IRCCS, University of Padova
Stefano Indraccolo
Istituto Oncologico Veneto IOV-IRCCS, University of Padova
Roberta Maestro
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Michele Milella
University of Verona
Paolo Morandi
“Dell’Angelo” Hospital, Mestre (VE)
Flavio Rizzolio
University Ca’ Foscari, Venice
Aldo Scarpa
University of Verona
Agostino Steffan
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Gianluca Tell
University of Udine
Nicola Normanno
National Cancer Institute, G. Pascale, Napoli
Maurizio D’Incalci
Humanitas Research Hospital and Humanitas University, Milano
Gabriella Sozzi
Fondazione IRCCS National Cancer Institute, Milano
Ilaria Guerriero
Biogem, Institute of Biology and Molecular Genetics, Ariano Irpino (AV)
Erica Torchiaro
Candiolo Cancer Institute FPO-IRCCS, Torino
Paola Allavena
Humanitas Research Hospital, Milano
Gustavo Baldassarre
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Fabrizio Bianchi
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG)
Giovanni Blandino
Regina Elena National Cancer Institute, Roma
Antonino Bruno
University of Insubria, Varese, Italy and IRCCS MultiMedica, Milan, Italy
Paola Chiarugi
University of Firenze
Federica Di Nicolantonio
University of Torino and Candiolo Cancer Institute FPO-IRCCS
A technical, pharmaceutical and publication exhibition will be held in the Congress Venue. For any information, please contact the Organizing Secretariat.
The 62th annual Meeting of the Italian Cancer Society will take place in:
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia, Italy
INFO: sic2022@meetingsrl.eu
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia, Italy
INFO: sic2022@meetingsrl.eu
The conference venue NH Laguna Palace
is fully booked.
For other hotel solutions please click on this link:
To get a 5% discount write “MEETCANC22” in the code and write “62nd annual Meeting of the Italian Cancer Society” in the “notes” section.
62° @SIC_cancer Annual Meeting
Three days of scientific breakthroughs, intense participation and inspiring poster discussions.
Watch our video!
62° @SIC_cancer Annual Meeting
Three days of scientific breakthroughs, intense participation and inspiring poster discussions.
Watch our video!
Event organized with the unrestricted grant of:
Precision oncology:
a reality from prevention to therapy
Venice, November 16th 2022
REGISTRATION
Click here to participate onsite
Click here to participate online